Evaluation of Combination Treatment Efficacy of PI3K Inhibitors in PC-3 and MCF7 Cell Viability Assays
10 Sept 2017Class I Phosphoinositide 3-kinase (PI3K) proteins have been extensively characterized with respect to their roles in cell proliferation and tumorigenesis, and therefore serve as desirable targets for oncogenic drug development. Class I PI3K isoform-specific inhibitors provide elucidation of the individual isoform functionality, and the dependence particular cell types have on it. In this application note, the impact of PI3K isoform-selective inhibitors on the viability of PC3 and MCF-7 prostate cancer cells is evaluated.
Related products
Request Quote for All Products
Echo® 500 Series Liquid Handlers
The Echo® liquid handler revolutionizes liquid handling with acoustic energy. Sound waves eject precisely sized droplets from a source onto a microplate, slide or other surface suspended above the source. This product does not use tips, pin tools or nozzles—completely eliminating contact between the instrument and the liquid. The Echo liquid handler provides powerful benefits: Tipless transfer, resulting in dramatic cost savings Improved information about sample integrity and improved transfer quality through measurement of DMSO hydration level Elimination of the need for calibration through Dynamic Fluid Analysis™ technology, a patented Labcyte process Elimination of cross-contamination, carryover or leachates through non-contact transfer Accurate, precise movement of nanoliter-scale quantities, enabling assay miniaturization and further reducing costs Better results through direct dilution of compounds, an improvement over serial dilution methods Greatly simplified assay development and dilution processes through the flexibility to transfer any volume of liquid from any well to any other well